(Q83946197)

English

Long-term survival benefit after adjuvant treatment of cutaneous melanoma with dacarbazine and low dose natural interferon alpha: A controlled, randomised multicentre trial

scientific article published on 01 January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16760174%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Long-term survival benefit after adjuvant treatment of cutaneous melanoma with dacarbazine and low dose natural interferon alpha: A controlled, randomised multicentre trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16760174%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Fredrik B. Thorén

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16760174%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Rudolf Stadler

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16760174%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Thomas Luger

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16760174%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Thomas Bieber

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16760174%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Ulrike Köhler

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16760174%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Ruthild Linse

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16760174%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Kristin Technau

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16760174%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Roland Schubert

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16760174%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Katja Schroth

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16760174%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Feredoun Vakilzadeh

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16760174%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Matthias Volkenandt

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16760174%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Harald Gollnick

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16760174%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Harald Von Eick

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16760174%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Orjan Strannegård

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16760174%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16760174%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Acta Oncologica

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16760174%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

45

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16760174%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16760174%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

389-399

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16760174%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

A pooled analysis of eastern cooperative oncology group and intergroup trials of adjuvant high-dose interferon for melanoma

1 reference

https://api.crossref.org/works/10.1080%2F02841860600630954

21 January 2018

Effect of long-term adjuvant therapy with interferon alpha-2a in patients with regional node metastases from cutaneous melanoma: a randomised trial.

1 reference

https://api.crossref.org/works/10.1080%2F02841860600630954

21 January 2018

Adjuvant interferon alpha 2b in high risk melanoma - the Scottish study

1 reference

https://api.crossref.org/works/10.1080%2F02841860600630954

21 January 2018

Randomised trial of interferon alpha-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases. French Cooperative Group on Melanoma

1 reference

https://api.crossref.org/works/10.1080%2F02841860600630954

21 January 2018

Does adjuvant systemic therapy with interferon-alpha for stage II-III melanoma prolong survival?

1 reference

https://api.crossref.org/works/10.1080%2F02841860600630954

21 January 2018

Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials

1 reference

https://api.crossref.org/works/10.1080%2F02841860600630954

21 January 2018

Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years?

1 reference

https://api.crossref.org/works/10.1080%2F02841860600630954

21 January 2018

Are all type I human interferons equivalent?

1 reference

https://api.crossref.org/works/10.1080%2F02841860600630954

21 January 2018

Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways

1 reference

https://api.crossref.org/works/10.1080%2F02841860600630954

21 January 2018

The neglected role of type I interferon in the T-cell response: implications for its clinical use

1 reference

https://api.crossref.org/works/10.1080%2F02841860600630954

21 January 2018

Tumour-infiltrating lymphocytes in metastatic malignant melanoma and response to interferon alpha treatment

1 reference

https://api.crossref.org/works/10.1080%2F02841860600630954

21 January 2018

Identifiers

10.1080/02841860600630954

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16760174%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16760174%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83946197&oldid=2083871521"